期刊文献+

The mechanisms of the relationship between glucocorticoids and cardiovascular diseases 被引量:1

The mechanisms of the relationship between glucocorticoids and cardiovascular diseases
原文传递
导出
摘要 To the editor: We have enjoyed reading an original article by Ji et al,1 entitled Influence of drug treatment on glucocorticoid receptor levels in patients with coronary heart disease, published in a recent issue of the Chinese Medical Journal. Herein, 80 patients with coronary artery disease were divided into four groups according to given drugs, and glucocorticoid (GC) receptor protein levels in peripheral blood lymphocytes were investigated before and I month after treatment in each group. In groups receiving beta blocker and nifedipine, increased levels were observed. They proposed that these increased levels might account for antiinflammatory effects of these drugs. To the editor: We have enjoyed reading an original article by Ji et al,1 entitled Influence of drug treatment on glucocorticoid receptor levels in patients with coronary heart disease, published in a recent issue of the Chinese Medical Journal. Herein, 80 patients with coronary artery disease were divided into four groups according to given drugs, and glucocorticoid (GC) receptor protein levels in peripheral blood lymphocytes were investigated before and I month after treatment in each group. In groups receiving beta blocker and nifedipine, increased levels were observed. They proposed that these increased levels might account for antiinflammatory effects of these drugs.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第23期3504-3504,共1页 中华医学杂志(英文版)
  • 相关文献

参考文献1

二级参考文献25

  • 1Libby P.Atherosclerosis:disease biology affecting the coronary vasculature.Am J Cardiol 2006; 98:3Q-9Q.
  • 2Ijem J,Granlie C.More than cholesterol:the complexity of coronary artery disease.S D J Med 2000; 53:489-491.
  • 3Libby P.Inflammation and cardiovascular disease mechanisms.Am J Clin Nutr 2006; 83:456S-460S.
  • 4Fearon WF,Fearon DT.Inflammation and cardiovascular disease:role of the interleukin-1 receptor antagonist.Circulation 2008; 117:2577-2579.
  • 5Rana JS,Nieuwdorp M,Jukema JW,Kastelein JJ.Cardiovascular metabolic syndrome-an interplay of,obesity,inflammation,diabetes and coronary heart disease.Diabetes Obes Metab 2007; 9:218-232.
  • 6Lesperance F,Frasure-Smith N.Depression in patients with cardiac disease:a practical review.J Psychosom Res 2000; 48:379-391.
  • 7Dominiczak MH.Deteriorating fuel metabolism,inflammation and coronary disease:are we closer to an all-encompassing theory? Curr Opin Lipidol 2003; 14:639-642.
  • 8Shively CA,Musselman DL,Willard SL.Stress,depression,and coronary artery disease:modeling comorbidity in female primates.Neurosci Biobehav Rev 2009; 33:133-144.
  • 9Shively CA,Register TC,Clarkson TB.Social stress,visceral obesity,and coronary artery atherosclerosis:product of a primate adaptation.Am J Primatol 2009; 71:742-751.
  • 10Gillespie CF,Nemeroff CB.Hypercortisolemia and depression.Psychosom Med 2005; 67 Suppl 1:S26-S28.

共引文献4

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部